Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection

Takehiro Okabayashi, Hiromichi Maeda, Zhao Li Sun, Robert A. Montgomery, Isao Nishimori, Kazuhiro Hanazaki

Research output: Contribution to journalArticle

Abstract

Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a closed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.

Original languageEnglish (US)
Pages (from-to)4116-4121
Number of pages6
JournalWorld Journal of Gastroenterology
Volume15
Issue number33
DOIs
StatePublished - 2009

Fingerprint

Insulin Infusion Systems
Insulin
Liver
Hypoglycemia
Critical Illness
Hyperglycemia
Endocrine System
Hospital Costs
Therapeutics
Diabetes Mellitus
Morbidity
Mortality
Incidence
Infection

Keywords

  • Artificial pancreas
  • Hepatic resection
  • Hyperglycemia
  • Intensive insulin therapy
  • Surgical site infection

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection. / Okabayashi, Takehiro; Maeda, Hiromichi; Sun, Zhao Li; Montgomery, Robert A.; Nishimori, Isao; Hanazaki, Kazuhiro.

In: World Journal of Gastroenterology, Vol. 15, No. 33, 2009, p. 4116-4121.

Research output: Contribution to journalArticle

Okabayashi, Takehiro ; Maeda, Hiromichi ; Sun, Zhao Li ; Montgomery, Robert A. ; Nishimori, Isao ; Hanazaki, Kazuhiro. / Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection. In: World Journal of Gastroenterology. 2009 ; Vol. 15, No. 33. pp. 4116-4121.
@article{db6e4d09ea5c43b4bebf33c12d3e2944,
title = "Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection",
abstract = "Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a closed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.",
keywords = "Artificial pancreas, Hepatic resection, Hyperglycemia, Intensive insulin therapy, Surgical site infection",
author = "Takehiro Okabayashi and Hiromichi Maeda and Sun, {Zhao Li} and Montgomery, {Robert A.} and Isao Nishimori and Kazuhiro Hanazaki",
year = "2009",
doi = "10.3748/wjg.15.4116",
language = "English (US)",
volume = "15",
pages = "4116--4121",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "33",

}

TY - JOUR

T1 - Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection

AU - Okabayashi, Takehiro

AU - Maeda, Hiromichi

AU - Sun, Zhao Li

AU - Montgomery, Robert A.

AU - Nishimori, Isao

AU - Hanazaki, Kazuhiro

PY - 2009

Y1 - 2009

N2 - Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a closed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.

AB - Postoperative hyperglycemia is common in critically ill patients, even in those without a prior history of diabetes mellitus. It is well known that hyperglycemia induced by surgical stress often results in dysregulation of liver metabolism and immune function, impairing postoperative recovery. Current evidence suggests that maintaining normoglycemia postoperatively improves surgical outcome and reduces the mortality and morbidity of critically ill patients. On the basis of these observations, several large randomized controlled studies were designed to evaluate the benefit of postoperative tight glycemic control with intensive insulin therapy. However, intensive insulin therapy carries the risk of hypoglycemia, which is linked to serious neurological events. Recently, we demonstrated that perioperative tight glycemic control in surgical patients could be achieved safely using a closed-loop glycemic control system and that this decreased both the incidence of infection at the site of the surgical incision, without the appearance of hypoglycemia, and actual hospital costs. Here, we review the benefits and requirements of perioperative intensive insulin therapy using a closed-loop artificial endocrine pancreas system in hepatectomized patients. This novel intensive insulin therapy is safe and effectively improves surgical outcome after hepatic resection.

KW - Artificial pancreas

KW - Hepatic resection

KW - Hyperglycemia

KW - Intensive insulin therapy

KW - Surgical site infection

UR - http://www.scopus.com/inward/record.url?scp=70449709144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449709144&partnerID=8YFLogxK

U2 - 10.3748/wjg.15.4116

DO - 10.3748/wjg.15.4116

M3 - Article

C2 - 19725143

AN - SCOPUS:70449709144

VL - 15

SP - 4116

EP - 4121

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 33

ER -